These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8579622)

  • 41. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
    Lai A; Zhang J; Ding L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary heart disease risk factors in relation to the menopause.
    Razay G; Heaton KW; Bolton CH
    Q J Med; 1992; 85(307-308):889-96. PubMed ID: 1484951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women.
    Scuteri A; Bos AJ; Brant LJ; Talbot L; Lakatta EG; Fleg JL
    Ann Intern Med; 2001 Aug; 135(4):229-38. PubMed ID: 11511137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Safety of hormone replacement therapy in menopause and its favorable effect on the lipid spectrum].
    Murín J; Borovský M; Payer J; Killinger Z; Stecová L
    Vnitr Lek; 1995 Oct; 41(10):672-6. PubMed ID: 8578697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
    Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
    JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women.
    Longcope C; Herbert PN; McKinlay SM; Goldfield SR
    J Clin Endocrinol Metab; 1990 Jul; 71(1):67-72. PubMed ID: 2115047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
    Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
    Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.
    Lindheim SR; Presser SC; Ditkoff EC; Vijod MA; Stanczyk FZ; Lobo RA
    Fertil Steril; 1993 Oct; 60(4):664-7. PubMed ID: 8405521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.
    Casper RF; Chapdelaine A
    Am J Obstet Gynecol; 1993 Apr; 168(4):1188-94; discussion 1194-6. PubMed ID: 8475965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.
    Tremollieres FA; Cigagna F; Alquier C; Cauneille C; Pouilles J; Ribot C
    Atherosclerosis; 2000 Nov; 153(1):81-8. PubMed ID: 11058702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.
    Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C
    Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Menopause-related changes in lipoproteins and some other cardiovascular risk factors.
    Bonithon-Kopp C; Scarabin PY; Darne B; Malmejac A; Guize L
    Int J Epidemiol; 1990 Mar; 19(1):42-8. PubMed ID: 2351523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
    Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
    Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian hormone status, life-style factors, and markers of bone metabolism in women aged 50 years.
    Leino A; Järvisalo J; Impivaara O; Kaitsaari M
    Calcif Tissue Int; 1994 Apr; 54(4):262-7. PubMed ID: 8062141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.